Flow Neuroscience trials drug-free depression treatment for NHS clinicians

Flow Neuroscience is expanding its NHS trial to offer a drug-free treatment for depression to eligible NHS clinicians. This trial, in partnership with the NHS Practitioner Health service, will provide front-line NHS clinicians with access to transcranial direct current stimulation (tDCS) treatment using the Flow device. This non-invasive treatment targets the left dorsolateral prefrontal cortex, an area of the brain associated with depression. Clinicians in the trial will wear the headset for 30 minutes a day at home, with the aim of providing an effective, drug-free treatment option for depression. This innovative approach aims to address the mental health crisis among NHS professionals and provide an alternative to antidepressants, especially for those who experience side effects. The trial is part of Flow’s broader NHS program, which aims to demonstrate the effectiveness and integration of the Flow device into NHS operations. Dr. Zaid Al-Najjar, medical director of NHS Practitioner Health, expressed excitement about the opportunity to offer eligible patients an evidence-based alternative treatment for depression through this collaboration with Flow Neuroscience.